Vaccitech stock drops 20% in Nasdaq debut - News - Dukascopy Bank

Sat, 01 May 2021 22:24:12 GMT
Source: Dukascopy Bank SA
 
Shares of a start-up behind the Oxford COVID-19 vaccine tech Vaccitech plunged about 20% in the Nasdaq debut, valuing the company at around $464M.

Back to feed
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.